NCT06228209
Tier - Palliative Care For Patients With Advanced Heart Failure or Cancer
Recruiting
NAAges 18+InterventionalHealth servicesIcahn School of Medicine at Mount SinaiInvestigator-initiated
~60 participants
Updated 2026-07-15 on ClinicalTrials.gov
What's tested:Tier-Palliative Care
At a glance
Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
The proportion of screened eligible patients
Measured over 3 months
Conditions
Where it's being run
1 sites across 1 statesNew York1
Study leadership
- Laura Gelfman, MD, MPH · PRINCIPAL_INVESTIGATOR · Icahn School of Medicine at Mount Sinai
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
Advanced Heart Failure (HF) with two HF-related hospitalizations within the last 12 months or
Advanced lung or non-colorectal gastrointestinal cancer (pancreatic, gastric, hepatobiliary, small bowel, esophageal) with one hospitalization within the last 6 months
KPS \> 50% (ECOG 0, 1 or 2)
\> 2 outpatient MSHS visits in prior 12 months
Manhattan residence
Capacity to provide informed consent
English or Spanish fluency
\> 18 years of age
Exclusion
Diagnoses of both cancer and advanced HF
Lung cancer with a driver mutation (e.g., EGFR) that confers a favorable prognosis and does not follow typical trajectory
Patients with \> 1 visit to Outpatient Supportive Oncology/Cardiology visit
Patients with last visit to Outpatient Supportive Oncology/Cardiology \< 3 months ago
Previous receipt of a ventricular assist device or previous heart transplantation
Receiving hospice care prior to study enrollment or enrolled in another study of a palliative care patient/caregiver intervention
Living in a facility (subacute rehab, long-term care facility, hospice facility or residence)
Callahan 6-Item Cognitive Screening score ≤3
What this trial measures
- The proportion of screened eligible patients3 months
The proportion of screened eligible patients that are enrolled in the trial.